These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35032359)

  • 1. Dermatological adverse effects of anti-glaucoma eye drops: a review.
    Patchinsky A; Petitpain N; Gillet P; Angioi-Duprez K; Schmutz JL; Bursztejn AC
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):661-670. PubMed ID: 35032359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety evaluation of benzalkonium chloride preserved eye-drops compared with alternatively preserved and preservative-free eye-drops in the treatment of glaucoma: a systematic review and meta-analysis.
    Hedengran A; Steensberg AT; Virgili G; Azuara-Blanco A; Kolko M
    Br J Ophthalmol; 2020 Nov; 104(11):1512-1518. PubMed ID: 32051133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between glaucoma eye drops and hyperemia.
    Yanagi M; Kiuchi Y; Yuasa Y; Yoneda T; Sumi T; Hoshikawa Y; Kobayashi M; Fukushima A
    Jpn J Ophthalmol; 2016 Mar; 60(2):72-7. PubMed ID: 26847553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating eye drop instillation technique in glaucoma patients.
    Gupta R; Patil B; Shah BM; Bali SJ; Mishra SK; Dada T
    J Glaucoma; 2012 Mar; 21(3):189-92. PubMed ID: 21336146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro evaluation for corneal damages by anti-glaucoma combination eye drops using human corneal epithelial cell (HCE-T)].
    Nagai N; Murao T; Oe K; Ito Y; Okamoto N; Shimomura Y
    Yakugaku Zasshi; 2011; 131(6):985-91. PubMed ID: 21628988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical/pharmacy claims databases.
    Schwartz GF; Kotak S; Mardekian J; Fain JM
    BMC Ophthalmol; 2011 Jun; 11():14. PubMed ID: 21672240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of preserved and preservative-free prostaglandin analogues for the treatment of open-angle glaucoma and ocular hypertension.
    Hommer A
    Drugs Today (Barc); 2010 Jun; 46(6):409-16. PubMed ID: 20571609
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    DI Staso S; Agnifili L; Cecannecchia S; DI Gregorio A; Ciancaglini M
    In Vivo; 2018; 32(2):211-220. PubMed ID: 29475902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between personality traits and experience of adverse periocular reactions to topical prostaglandin analogues.
    Kishimoto N; Noro T; Kodaka F; Kurosawa M; Itoh Y; Ogawa S; Watanabe T; Kubota M; Hori K; Shigeta M; Nakano T
    BMJ Open Ophthalmol; 2022 Jun; 7(1):. PubMed ID: 36161860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.
    Ramli N; Supramaniam G; Samsudin A; Juana A; Zahari M; Choo MM
    Optom Vis Sci; 2015 Sep; 92(9):e222-6. PubMed ID: 25730335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin analogues: A double-edged sword in orbital glaucoma disease management.
    Joganathan V; Cannon PS; Mercieca K
    Eur J Ophthalmol; 2021 May; 31(3):NP40-NP44. PubMed ID: 32043370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral drug-induced ocular pseudopemphigoid.
    Gibran SK
    Eye (Lond); 2004 Dec; 18(12):1270. PubMed ID: 15044940
    [No Abstract]   [Full Text] [Related]  

  • 13. Ocular surface status in glaucoma and ocular hypertension patients with existing corneal disorders switched from latanoprost 0.005% to tafluprost 0.0015%: comparison of two prostaglandin analogues with different concentrations of benzalkonium chloride.
    Wong TT; Aung T; Ho CL
    Clin Exp Ophthalmol; 2018 Dec; 46(9):1028-1034. PubMed ID: 29802759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New glaucoma medications in the geriatric population: efficacy and safety.
    Novack GD; O'Donnell MJ; Molloy DW
    J Am Geriatr Soc; 2002 May; 50(5):956-62. PubMed ID: 12028187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma.
    Seong HJ; Lee K; Lee SJ; Kim S; Park JW
    Korean J Ophthalmol; 2021 Jun; 35(3):235-241. PubMed ID: 34120423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication.
    Pisella PJ; Pouliquen P; Baudouin C
    Br J Ophthalmol; 2002 Apr; 86(4):418-23. PubMed ID: 11914211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tafluprost--a novel prostaglandin F2alpha analogue].
    Petrov SIu
    Vestn Oftalmol; 2014; 130(5):85-95. PubMed ID: 25711069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of preservative-free eye drops containing a fixed combination of dorzolamide and timolol in glaucoma patients.
    Renieri G; Führer K; Scheithe K; Lorenz K; Pfeiffer N; Thieme H
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):597-603. PubMed ID: 20977366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiglaucoma drops--with or without preservatives].
    Zemba M
    Oftalmologia; 2009; 53(2):26-30. PubMed ID: 19697836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modification of tear film break-up time by beta blocker eyedrops without preservatives].
    Marquardt R; Schubert T
    Klin Monbl Augenheilkd; 1991 Aug; 199(2):75-8. PubMed ID: 1960936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.